North Wales NHS funding for Bangor research centre stays in place despite audit criticism
The Betsi Cadwaladr University Health Board is still paying Bangor University for research staff months after an internal report questioned whether the arrangement is delivering any clear benefit to patients in north Wales.
Figures show the health board is due to pay £110,686 this financial year to support two researchers at the Centre for Mental Health and Society. The centre is part of Bangor University but operates from offices belonging to the health board in Wrexham.
A January internal NHS report was blunt in its assessment. It said it was unclear what services the health board was receiving in return, and whether the arrangement was helping the local population. The same review concluded that the health board could not demonstrate value for money from the agreement, which has now been running for years without a full review.
The issue is not simply one of accounting. In a health system under pressure, every recurring payment has to justify itself against direct patient need, workforce shortages, and service demand. When a research partnership has been left to continue without a formal reassessment, the question moves from academic collaboration to stewardship of public money.
A five-year contract that kept rolling on
The agreement between the health board and Bangor University began as a five-year contract in 2012, but it was not reviewed and was allowed to continue. By September 2025, more than £4m of NHS money had been paid to the university under the arrangement, according to the internal report.
For this financial year, the payment covers two staff posts linked to the research centre. The health board said the current research topics include students’ experience in prison, mental health outcomes, and opiate use in primary care. Those are not trivial subjects. Each sits close to the practical realities of service planning, addiction care, and the mental health burden seen across communities in north Wales.
Yet relevance alone does not resolve the governance problem. Publicly funded research can be clinically useful and still fail to satisfy the basic test of whether the local commissioner knows exactly what is being bought, what outputs are expected, and how those outputs improve care.
Questions over patient benefit and value for money
The internal review said it was unclear what services the health board was receiving and paying for, and how beneficial the work was to the population of north Wales. In plain terms, the concern was not that research was happening, but that the health board could not show a direct or measurable return for the money spent.
Geoff Ryall-Harvey, regional director for North Wales at the health and social care watchdog Llais, said he would have expected a serious review of what was being purchased before the contract continued. He said NHS money is limited and health boards need to get best value for money from it, adding that there is a procedure to make sure research is relevant locally. He also said he would like to see what people in North Wales are getting for the £110,000 payment.
His comments go to the core of the dispute. Research partnerships often sit in a gray zone between service delivery and academic enquiry. They can strengthen evidence-based practice, support workforce development, and connect local services to university expertise. But the financial relationship still needs tight oversight. Without it, a long-running agreement can drift from targeted investment into inertia.
The fact that the centre is based in Wrexham and uses health board premises makes the governance question more immediate. Shared space, shared work, and shared branding do not automatically mean shared accountability.
Health board says governance is being strengthened
Teresa Owen, interim deputy chief executive, said research, development and innovation is an important part of the work of university health boards. She said the health board maintains good relationships with academic institutions, including Bangor University, and that it recognises the importance of good governance around research collaborations.
She said the board is addressing concerns raised in the internal audit review and is commissioning an external review of its research, development and innovation function. That review, she said, will also inform the strengthening of governance in this area.
Those assurances matter because the problem identified by the audit is structural rather than episodic. A report that asks what is being received for the money suggests weak contract management, unclear deliverables, or both. An external review may help set clearer rules for future collaborations, but it does not erase the years in which the agreement was left in place without the scrutiny it needed.
No fraud alleged, but scrutiny remains unresolved
Both the NHS and the university have reviewed the agreement and say there was no evidence of fraud or misconduct in the way it was set up and has operated. That finding narrows the issue considerably. This is not presented as a case of wrongdoing, but as a case of weak oversight and poor transparency in a public funding relationship.
Bangor University said the Centre for Mental Health and Society focuses on research with direct application to improving the mental wellbeing of the general population or improving mental health care. It said the university remains committed to working constructively with the health board and will engage in any discussions or review processes if asked.
The center’s research focus suggests it is operating in an area where the boundary between service improvement and academic output can be especially thin. Mental health, opioid use, and prison-related experience are all topics with clear clinical relevance. They also require a defined local strategy if the public purse is being used to sustain dedicated posts.
One sentence captures the tension more sharply than any administrative language can. More than £4m has already gone from NHS funds to the university under this agreement.
What the case leaves hanging
The central unresolved question is not whether research has value in principle. It is whether this specific arrangement has been designed, monitored, and renewed in a way that makes that value visible to the NHS and to patients in north Wales.
Until the external review is complete, the contract remains a live test of public sector governance: whether a long-standing university-health board partnership can demonstrate clear outputs, local benefit, and a defensible use of limited NHS money. The audit has already said the evidence is not there. The next step is whether the board can produce it.